Table 4.
Groups | Nuclear pyknosis | Fat deposit |
---|---|---|
Control | 0.08 ± 0.02 | 0.12 ± 0.01 |
Diabetic | 1.64 ± 0.21### | 2.06 ± 0.15### |
Diabetic + glibenclamide | 1.10 ± 0.07###,* | 1.40 ± 0.09###,*** |
Diabetic + EBRE (100 mg/kg) | 1.20 ± 0.14### | 1.82 ± 0.11### |
Diabetic + EBRE (200 mg/kg) | 1.14 ± 0.10### | 1.64 ± 0.08###,* |
Diabetic + EBRE (400 mg/kg) | 1.02 ± 0.07###,** | 1.50 ± 0.06###,** |
EBRE, Eryngium billardieri root extract. *P < 0.05, **P < 0.01, and ***P < 0.001 indicate significant differences compared to the diabetic group; ###P < 0.001 versus control group.